The Vilex/DuVal Cannulated Bone Screw, as designed, has the following Indications for Use: Bone Fractures, Osteotomies, Arthrodeses, Osteochrondritis and Tendon Reattachment. It is intended for, but not limited to. Hand Surgery, Orthopedic Surgery, Plastic Surgery and Podiatric Surgery. The materials manufacture this screw are 316L, implant-quality used to stainloss steel and Ti6Al4V, implant-quality titanium. When properly with Vilex instrumentation, used this screw safe purchase and compression for cortical and achieves cancellous bone fixation in the human body.
Device Story
Cannulated bone screws designed for internal fixation of bone fractures, osteotomies, and arthrodeses; used in hand, orthopedic, plastic, and podiatric surgery. Screws provide purchase and compression for cortical and cancellous bone fixation. Operated by surgeons using specialized Vilex instrumentation. Device facilitates bone healing by stabilizing bone segments. Manufactured from implant-quality 316L stainless steel or Ti6Al4V titanium.
Clinical Evidence
Bench testing only.
Technological Characteristics
Materials: 316L implant-quality stainless steel and Ti6Al4V implant-quality titanium. Form factor: Cannulated screw design. Function: Bone fixation and compression. Energy source: None (mechanical).
Indications for Use
Indicated for bone fractures, osteotomies, arthrodeses, osteochondritis, and tendon reattachment in patients requiring orthopedic, hand, plastic, or podiatric surgery.
Regulatory Classification
Identification
A smooth or threaded metallic bone fixation fastener is a device intended to be implanted that consists of a stiff wire segment or rod made of alloys, such as cobalt-chromium-molybdenum and stainless steel, and that may be smooth on the outside, fully or partially threaded, straight or U-shaped; and may be either blunt pointed, sharp pointed, or have a formed, slotted head on the end. It may be used for fixation of bone fractures, for bone reconstructions, as a guide pin for insertion of other implants, or it may be implanted through the skin so that a pulling force (traction) may be applied to the skeletal system.
Related Devices
K991151 — VILEX CANNULATED BONE SCREW, DUVAL CANNULATED BONE SCREW, ORTHEX CANNULATED BONE SCREW · Vilex, Inc. · Apr 26, 1999
K102343 — EMERGE MEDICAL CANNULATED SCREW FIXATION SYSTEM · Emerge Medical · Nov 23, 2010
K973309 — VILEX CANNULATED BONE SCREW, DUVAL CANNULATED BONE SCREW · Vilex, Inc. · Jan 16, 1998
K222967 — Avanti Orthopaedics 2.2mm and 2.7mm Cannulated Screws, Avanti Orthopaedics 3.2mm and 4.0mm Cannulated Screws · Avanti Orthopaedics, Inc. · Nov 23, 2022
Submission Summary (Full Text)
{0}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/0/Picture/1 description: The image shows the words "Public Health Service" in a simple, sans-serif font. The text is black against a white background. The word "Public" is on the first line, "Health" is on the second line, and "Service" is on the third line.
Image /page/0/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circle with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized symbol that resembles an abstract human figure with three curved lines representing the body and arms.
APR 3 0 1999
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Abrahim Lavi, Ph.D., M.B.A. President/CEO Vilex, Inc. 1801 Route 51 Building 10 Large, Pennsylvania 15025-0724
- K991151 and K991197 Re: Trade Name: Cannulated Screws Regulatory Class: II Product Code: HWC Dated: April 1 and 6, 1999 Received: April 6 and 8, 1999
Dear Dr. Lavi:
This letter is being issued in response to your conversation with Mr. Aric Kaise on April 28, I his letter is being issued in response to your conclosed with our letter dated April 1999, in which you stated the materials used to manufacture some of the screws 26, 1999, Inconectly deserted the materials abouts and the corrected Intended Use Aornis are described by the submissions releveled about of the mace our letter dated April 26, 1999.
enclosed and this letter is intended to supercede and replace our letter dated April
We have reviewed your Section 510(k) notification of intent to market the devices we liave leviewed your bection 910(t) is the devices are substantially equivalent (for the indications for use stated in the enclosures) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that to may been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the devices, subject to the general controls Costicity Act (Ticl). "Toweral controls provisions of the Act include requirements for provisions of and now its ing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your devices are classified (see above) into either class II (Special Controls) or class III (Premarket Approval), they may be subject to such additional controls. Existing major regulations affecting your devices can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify the assumptions. Failure to comply with the GMP regulation may result in regulatory
{1}------------------------------------------------
Page 2 - Abrahim Lavi, Ph.D., M.B.A.
action. In addition, FDA may publish further announcements concerning your devices in the Federal Register. Please note: this response to your premarket notification submission does not allect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your devices as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your devices to a legally marketed predicate device results in a classification for your devices and thus, permits your devices to proceed to the market.
If you desire specific advice for your devices on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your devices, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or at (301) 443-6597, or at its Internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Cella M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosures
{2}------------------------------------------------
1 of 1 Page
510 (k) NUMBER (IF KNOWN) : K9911A7
Vilex Cannulated Bone Screw/DuVal Cannulated Bone Screw DEVICE NAME:
INDICATIONS FOR USE:
The Vilex/DuVal Cannulated Bone Screw, as designed, has the following Indications for Use: Bone Fractures, Osteotomies, Arthrodeses, Osteochrondritis and Tendon Reattachment. It is intended for, but not limited to. Hand Surgery, Orthopedic Surgery, Plastic Surgery and Podiatric Surgery. The materials manufacture this screw are 316L, implant-quality used to stainloss steel and Ti6Al4V, implant-quality titanium. When properly with Vilex instrumentation, used this screw safe purchase and compression for cortical and achieves cancellous bone fixation in the human body.
(PLEASE DO NOT HRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF DACE
IF NEEDED.) IF NEEDED.)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use (Per 21 CFR 801.109)
OR
Over-The-Counter Use
(Optional Format 1-2-96)
(Division Sign-Off)
Division of General Restorative Devices
510(k) Number 1991197
6.1
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.